Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 115Brain Neoplasms 114Prostatic Neoplasms 101Neoplasm Metastasis 79Carcinoma, Hepatocellular 69Lung Neoplasms 67Pancreatic Neoplasms 64Breast Neoplasms 48Melanoma 37Carcinoma, Renal Cell 33Neoplasms 31Squamous Cell Carcinoma of Head and Neck 21Colorectal Neoplasms 20Liver Neoplasms 19Glioblastoma 18Small Cell Lung Carcinoma 14Head and Neck Neoplasms 14Sarcoma 11Kidney Neoplasms 11Glioma 10Recurrence 8Urinary Bladder Neoplasms 7Radiation Injuries 6Neuroma, Acoustic 6Cholangiocarcinoma 6Adenocarcinoma 6Uveal Melanoma 5Uterine Cervical Neoplasms 5Prostate Cancer Metastatic 5Ovarian Neoplasms 5

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 9Papillomavirus Vaccines 8Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 8Surveys and Questionnaires 6Educational Status 6Blood Specimen Collection 5Vaginal Smears 4Radiotherapy, Intensity-Modulated 4Methods 4Human Papillomavirus DNA Tests 4Early Intervention, Educational 4Cisplatin 4Carboplatin 4Patient Navigation 3Mass Screening 3Taxes 2Standard of Care 2Radiation 2Practice Guidelines as Topic 2Papanicolaou Test 2Paclitaxel 2Motivational Interviewing 2Interviews as Topic 2Electrocoagulation 2Docetaxel 2Cytological Techniques 2Cryotherapy 2Colposcopy 2utomilumab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Papillomavirus Infections × Radiosurgery × Clear all
NCT07578467 2026-05-11

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

University of Pennsylvania

Phase 1/2 Not yet recruiting
35 enrolled

Carcinoma, Squamous Cell, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡